Skip to content

Complete Blood Count (CBC) Test

Published: August 9, 2026Updated: August 16, 2026

This test detects the presence of Bacillus anthracis (anthrax) bacteria DNA in blood using advanced molecular methods when a blood culture shows suspicious growth.

Quick summary

{"Detects anthrax bacteria DNA in blood samples","Used when initial blood culture shows possible Bacillus growth","Results help confirm or rule out anthrax infection","Performed using Nucleic Acid Amplification (NAA) technology","Positive result requires immediate medical attention"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
101370-5
Short code
ANTHpXO2
Synonyms
B anthracis plsmd pXO2 DNA Bld Pos Ql
Category
chemistry
Sample
whole-blood
Container
Sterile blood culture bottle (aerobic and/or anaerobic) flagged positive by continuous-monitoring blood culture instrument
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
0–120 years
Method
non-probe-amp-tar
CPT
87798
SNOMED
1089521000119102
Specimen volume
Positive blood culture broth aliquot (typically 0.5-1 mL drawn aseptically from the positive blood culture bottle)
Stability
Test should be performed as soon as possible after the blood culture flags positive. If testing is delayed, store at 2-8°C for up to 24 hours or freeze at -70°C for longer preservation; avoid repeated freeze-thaw cycles
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

The Complete Blood Count (CBC) is a common blood test that measures the different cells circulating in your blood, including red blood cells, white blood cells, and platelets, to help evaluate your overall health.

The Bacillus anthracis pXO2 DNA test is a specialized molecular test that detects the presence of DNA from Bacillus anthracis, the bacteria that causes anthrax. This test specifically looks for the pXO2 plasmid, which is one of two key genetic elements (plasmids) that the anthrax bacteria need to cause disease. The test is performed using Nucleic Acid Amplification (NAA) technology, which can detect even small amounts of bacterial DNA with high accuracy.

Your doctor may order this test as part of a routine checkup, to investigate symptoms such as fatigue, weakness, fever, or unusual bruising, to help diagnose conditions like anemia or infection, or to monitor how a treatment is working over time.

This test is ordered when a blood culture (a test to detect bacteria in the blood) has already shown growth of organisms that may be Bacillus anthracis. Not all Bacillus bacteria cause anthrax—some are harmless environmental bacteria. This confirmatory test helps determine whether the bacteria found in the blood culture is actually the dangerous anthrax bacterium.

The test is performed by drawing a small sample of blood from a vein, usually in your arm. A healthcare professional cleans the site, inserts a thin needle, and collects the sample into a tube, which typically takes only a few minutes.

A healthcare provider collects a blood sample from a vein in your arm. The sample is then sent to a laboratory where technicians use specialized molecular techniques to detect the specific pXO2 DNA sequence unique to Bacillus anthracis. The test does not require probe detection and uses nucleic acid amplification methods to identify the bacterial genetic material.

Results show whether your blood cell counts fall within normal ranges. Values that are too high or too low can point to conditions such as infection, anemia, inflammation, or clotting problems, and your doctor will interpret them together with your symptoms and medical history.

A 'Positive' result means that Bacillus anthracis DNA was detected in your blood sample, which confirms an anthrax infection. This is a serious finding that requires immediate medical treatment. A 'Negative' result means that no anthrax bacteria DNA was detected, suggesting the bacteria found in the initial culture is not anthrax. Your healthcare provider will interpret these results in context with your symptoms and other test findings.

Reference range

Negative (Bacillus anthracis pXO2 plasmid DNA not detected)N/A

Specimen: whole-blood

No special patient preparation required. Testing is performed on an existing positive blood culture specimen; no additional venipuncture is typically needed for this confirmatory assay.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is critical for confirming anthrax infection, a serious and potentially life-threatening disease. Anthrax can occur in three main forms: cutaneous (skin), inhalational (lungs), and gastrointestinal (digestive system). Early detection through molecular testing allows for prompt antibiotic treatment, which is essential for survival, especially in inhalational anthrax. The pXO2 plasmid is essential for the bacteria's survival in the blood and immune system evasion, making its detection highly specific for pathogenic Bacillus anthracis.

Clinical significance also includes public health implications, as anthrax is considered a potential bioterrorism agent. Confirmed cases must be reported to public health authorities. This test helps differentiate true anthrax infections from other Bacillus species that may contaminate samples or cause opportunistic infections, particularly in immunocompromised patients.

Frequently asked questions

Is anthrax contagious from person to person?
Anthrax is generally not contagious between people. You cannot catch anthrax from someone who is infected through casual contact. However, in rare cases, contact with anthrax skin lesions can transmit the bacteria, though this is uncommon.
How long does it take to get results?
This specialized test is performed at reference laboratories with molecular testing capabilities. Results typically take 1-3 days after the blood culture shows growth. Your healthcare provider will contact you with results as soon as they are available.
What are the symptoms of anthrax?
Symptoms vary by type of anthrax: Cutaneous anthrax causes skin ulcers with a black center; Inhalational anthrax starts with flu-like symptoms followed by severe breathing problems; Gastrointestinal anthrax causes nausea, vomiting, and abdominal pain. All forms can progress to life-threatening bloodstream infection if untreated.
Who is at risk for anthrax?
People at higher risk include those who handle animals or animal products (veterinarians, farmers, livestock workers), laboratory workers handling anthrax specimens, and individuals exposed to bioterrorism events. Most cases are related to occupational exposure or contaminated animal products.
What happens if my test is positive?
If the test is positive, you will receive immediate antibiotic treatment, often starting before results are confirmed. Treatment typically involves intravenous antibiotics such as ciprofloxacin or doxycycline. Close monitoring and sometimes additional treatments may be necessary depending on the form and severity of infection.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy